Spiracur develops mechanically powered negative pressure wound therapy devices, including the SNaP System and the ciSNaP Closed Incision System. Its SNaP System is a 2.2‑ounce, battery‑free NPWT device that allows patient mobility and operates silently; both devices have received FDA 510(k) clearance and CE Mark approval. The company was founded out of the Stanford Biodesign Innovation Program in 2007 and is privately held. Spiracur says its technology is designed to be portable and disposable to address limitations of traditional NPWT systems. With the announced financing, the company plans to launch new products into new care settings, expand globally, and grow sales, marketing and R&D investment. The $16 million financing from GE Capital supports those commercialization and expansion efforts. Spiracur is a Sunnyvale, California developer of an ultraportable, single-use negative pressure wound therapy (NPWT) device called the SNaP Wound Care System. The SNaP device eliminates the need for an electric or battery-powered pump, is silent, and weighs only 2.2 ounces so it can fit under a patient’s clothing. The SNaP System received FDA clearance in August 2009 and obtained CE Mark approval in December 2010. The company plans to use new capital to fund commercialization of the SNaP Wound Care System throughout the United States and the European Union and to support further R&D. Spiracur closed a $35M equity financing to support those efforts. Eric J. Kim of Maverick Capital joined the company’s board in conjunction with the financing. Spiracur is a medical-device developer that makes a device used to heal small wounds effectively. The company raised $20.3 million in a second round of funding reported by VentureWire. Investors in the round were Kleiner Perkins Caufield & Byers, New Leaf Venture Partners and De Novo Ventures. Spiracur has raised $24.3 million since its inception in 2007. The technology is based on work from a bio-design program at Stanford University. The company is based in Redwood City, Calif., and the articles note that not much is known publicly about its underlying technology.

Total raised

$71M

Funding rounds

3

Latest round

Debt Financing

Latest activity

Nov 2014